Log In
Print this Print this

Betamethasone Foam

  Manage Alerts
Collapse Summary General Information
Company Foamix Pharmaceuticals Ltd.
DescriptionTopical foam 0.12% betamethasone valerate
Molecular Target Glucocorticoid receptor (GCCR)
Mechanism of ActionGlucocorticoid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I/II
Standard IndicationPsoriasis
Indication DetailsTreat plaque psoriasis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today